ONE Bio (OTCMKTS:ONBI) versus Cronos Group (NASDAQ:CRON) Head-To-Head Comparison

ONE Bio (OTCMKTS:ONBI) and Cronos Group (NASDAQ:CRON) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for ONE Bio and Cronos Group, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ONE Bio 0 0 0 0 N/A
Cronos Group 2 4 2 0 2.00

Cronos Group has a consensus target price of $8.19, indicating a potential downside of 3.34%. Given Cronos Group’s higher probable upside, analysts plainly believe Cronos Group is more favorable than ONE Bio.

Insider & Institutional Ownership

11.8% of Cronos Group shares are owned by institutional investors. 7.9% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares ONE Bio and Cronos Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ONE Bio N/A N/A N/A
Cronos Group 266.31% -1.61% -1.41%

Earnings and Valuation

This table compares ONE Bio and Cronos Group’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ONE Bio N/A N/A N/A N/A N/A
Cronos Group $25.64 million 117.66 $1.17 billion $0.67 12.64

Cronos Group has higher revenue and earnings than ONE Bio.

Volatility and Risk

ONE Bio has a beta of -6.58, indicating that its share price is 758% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.

Summary

Cronos Group beats ONE Bio on 7 of the 9 factors compared between the two stocks.

About ONE Bio

ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-ecological products and over-the-counter products utilizing the extractions of tobacco leaves and various other plant materials. It produces chemical and herbal extracts for use in a range of health and wellness products, including chemical extracts comprising Solanesol and Coenzyme Q10; and herabal extracts, such as Resveratrol, 5-Hydroxytryptophan, Ganoderma Tea, and powdered and particulate fertilizers. This business unit distributes its products through independent third party distributors, universities, and hospital research centers to the bio-health industry and raw chemical intermediates industry in the People's Republic of China. The OP business unit manufactures various consumer and commercial use health and energy drinks, organic food products, and fertilizers primarily based on bamboo in the People's Republic of China. Its products include boiled bamboo shoot cans, boiled bamboo shoot cans with vacuum packing, boiled mixed vegetables, and boiled seasoned vegetables, as well as Kamameshi, a Japanese rice dish. This segment distributes its products directly to supermarket chains, hotels, hospitals, and restaurants, as well as through a network of independent third party distributors. ONE Bio Corp. exports its products to Japan, southeast Asia, Europe, and North America. The company was formerly known as ONE Holdings, Corp. and changed its name to ONE Bio Corp. in November 2009. ONE Bio Corp. was incorporated in 2000 and is headquartered in Aventura, Florida.

About Cronos Group

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

Receive News & Ratings for ONE Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ONE Bio and related companies with MarketBeat.com's FREE daily email newsletter.